Bottom line
Is SPIT a good fund? The bottom line
SPIT is a managed large blend ETF from Rbb.
It charges 0.9% — about $90 a year on every $10,000 invested, more expensive than 56% of large blend funds we track.
It returned +38.5% over one year, +16.0% a year over five years, +17.5% a year over ten (as of Dec 31, 2025, per its prospectus).
With $33.4 million in net assets and 49 holdings, its largest position is Corcept Therapeutics Inc (5.4%) and the top 10 make up 34.6% of the portfolio.
What stands out
- 5-year return beat 95% of category peers
What to watch
- Small fund ($33.4 million) — small funds are likelier to close
- High turnover (111% a year) can mean more taxable distributions
Updated Nov 19, 2026
What SPIT invests in
The investment objective of the F/m Emerald Special Situations ETF (the Fund) is to seek long-term growth through capital appreciation.
The Fund is an actively managed exchange-traded fund (ETF) and invests primarily in equity securities of companies experiencing unique, idiosyncratic situations and transformations (Special Situations), selected by Emerald Mutual Fund Advisers Trust (the Sub-Adviser), the Funds investment sub-adviser, under the supervision of the Adviser. The Sub-Advisers research staff conducts company-specific research analysis to identify securities of the companies in which an unusual and possibly non-repetitive development is taking place which, in the opinion of the Sub-Adviser, may cause the securities to attain a higher market value independently, to a degree, than the trend in the securities market in general. Under normal market conditions, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity securities issued by companies…
From the fund's prospectus (filed Sep 8, 2026).
SPIT performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| SPIT | +38.5% | +16.0% | +17.5% |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What SPIT costs
On a $10,000 investment, SPIT's 0.9% expense ratio costs about $90 a year. The prospectus estimates $1,108 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
SPIT top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Corcept Therapeutics Inc CORT | 5.38% |
| 2 | TETRA Technologies Inc TTI | 3.95% |
| 3 | Amazon.com Inc AMZN | 3.89% |
| 4 | Guardant Health Inc GH | 3.59% |
| 5 | LivaNova PLC LIVN | 3.14% |
| 6 | Excelerate Energy Inc EE | 3.09% |
| 7 | Credo Technology Group Holding CRDO | 3.04% |
| 8 | Arlo Technologies Inc ARLO | 3.04% |
| 9 | Take-Two Interactive Software TTWO | 2.77% |
| 10 | Skyward Specialty Insurance Gr SKWD | 2.72% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 34.6% of the fund. See all top 25 holdings and asset mix →